Study Stopped
Adherence and recruitment issues.
Sponsor study identifier
interventional
26
1 country
1
Study Start
February 18, 2024
Actual (reported)Primary Completion
January 11, 2026
Actual (reported)Study Completion
January 11, 2026
Actual (reported)To evaluate the effects of osteopathic manipulative treatment in patients affected by symptoms related to gastro-oesophageal reflux disease (GERD)
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 11, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 18, 2024
Actual (reported)February 29, 2024
Actual (reported)March 19, 2024
Actual (reported)January 11, 2026
Actual (reported)January 11, 2026
Actual (reported)Mean change in GERD-HRQL
best possible score: 0, worst possible score: 50
At week 2, 4 an 8.
Adverse effects
Type and number.
At week 2, 4 and through study completion (8 weeks)
Exercise adherence
through study completion (8 weeks)
Change in drugs use
At week 2, 4 and 8.
Participants will receive four OMTs at week 1, 2, 4 and 8. Joint mobilization techniques for ribs, cervical and dorsal spine, as well as visceral treatment, soft-tissue release on diaphragm and abdominal wall will be used.
This group will receive OMTs and five breathing exercises to perform daily at home. A recorded video of the exercises will be provided to participants in this group.
Manual therapy on different area of the body.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
CTFO
Saronno, Varese, 21047, Italy
26 participants (actual enrollment reported by the registry).
First Submitted
February 29, 2024
First Posted
March 19, 2024
Study Start
February 18, 2024
Actual (reported)Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor
Usual care group (PPI or reflux suppressant)
Contact the study team to confirm eligibility.
Primary Completion
January 11, 2026
Actual (reported)Study Completion
January 11, 2026
Actual (reported)Last Updated
July 7, 2026
Record last verified: 2026-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: